Faculty Opinions recommendation of Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725813579.793529339 ◽

2017 ◽

Author(s):

Paul Drawz

Keyword(s):

Resistant Hypertension ◽

Crossover Trial ◽

Optimal Treatment ◽

Drug Resistant ◽

Double Blind

Download Full-text

Faculty Opinions recommendation of Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725813579.793527682 ◽

2017 ◽

Author(s):

Robert Widdop

Keyword(s):

Resistant Hypertension ◽

Crossover Trial ◽

Optimal Treatment ◽

Drug Resistant ◽

Double Blind

Download Full-text

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

The Lancet ◽

10.1016/s0140-6736(15)00257-3 ◽

2015 ◽

Vol 386 (10008) ◽

pp. 2059-2068 ◽

Cited By ~ 498

Author(s):

Bryan Williams ◽

Thomas M MacDonald ◽

Steve Morant ◽

David J Webb ◽

Peter Sever ◽

...

Keyword(s):

Resistant Hypertension ◽

Crossover Trial ◽

Optimal Treatment ◽

Drug Resistant ◽

Double Blind

Download Full-text

Faculty Opinions recommendation of Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725813579.793516057 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Resistant Hypertension ◽

Crossover Trial ◽

Optimal Treatment ◽

Drug Resistant ◽

Double Blind

Download Full-text

Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension

BMJ Open ◽

10.1136/bmjopen-2015-008951 ◽

2015 ◽

Vol 5 (8) ◽

pp. e008951 ◽

Cited By ~ 6

Author(s):

Bryan Williams ◽

Thomas M MacDonald ◽

Mark Caulfield ◽

J Kennedy Cruickshank ◽

Gordon McInnes ◽

...

Keyword(s):

Resistant Hypertension ◽

Crossover Trial ◽

Optimal Treatment ◽

Drug Resistant ◽

Prevention And Treatment ◽

Treatment Of Hypertension

Download Full-text

1367: A Randomised Double Blind Crossover Trial of Melatonin to Treat Nocturia in Men with Benign Prostatic Hypertrophy

The Journal of Urology ◽

10.1016/s0022-5347(18)38592-6 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 360-360

Author(s):

Marcus J. Drake ◽

Jeremy G. Noble ◽

Ian Mills

Keyword(s):

Crossover Trial ◽

Benign Prostatic Hypertrophy ◽

Prostatic Hypertrophy ◽

Double Blind

Download Full-text

A Randomized, Double-Blind, Crossover Trial of Modafinil on Mood

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70776-x ◽

2008 ◽

Vol 2008 ◽

pp. 198-199

Author(s):

J.C. Ballenger

Keyword(s):

Crossover Trial ◽

Double Blind

Download Full-text

ACCURATE PAIN REPORTING TRAINING DIMINISHES THE PLACEBO RESPONSE: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, CROSSOVER TRIAL

10.26226/morressier.598b05d9d462b80290b539fe ◽

2017 ◽

Author(s):

Roi Treister

Keyword(s):

Crossover Trial ◽

Placebo Response ◽

Double Blind ◽

Pain Reporting

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1070820.523755 ◽

2007 ◽

Author(s):

Andrew Wilcock

Keyword(s):

Advanced Cancer ◽

Crossover Trial ◽

Double Blind ◽

Effect Of Oxygen

Download Full-text

Faculty Opinions recommendation of Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1168153.630287 ◽

2009 ◽

Author(s):

Joel Katz ◽

Hance Clarke

Keyword(s):

Neuropathic Pain ◽

Crossover Trial ◽

Double Blind ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13445981.14821086 ◽

2012 ◽

Author(s):

Luca Persani

Keyword(s):

Crossover Trial ◽

Metabolic Effects ◽

Double Blind

Download Full-text